This invention relates to a bioavailable oral dosage form comprising of amorphous cefuroxime axetil containing from 7 to 25% crystalline cefuroxime axetil.

Esta invención se relaciona con una forma de dosificación oral bioavailable que abarca del axetil amorfo del cefuroxime que contiene a partir el axetil cristalino del cefuroxime del 7 a del 25%.

 
Web www.patentalert.com

< (none)

< Near field magneto-optical head having read and write pinhole apertures

> Waste processing system and related methods

> (none)

~ 00021